SCOPUS 정보 검색 플랫폼

Volumn 8, Issue 1, 2001, Pages 39-50

Reversal of multidrug resistance by the P-glycoprotein modulator, LY335979, from the bench to the clinic

(8) Perego, Paola a Corna, Elisabetta a De Cesare, Michelandrea a Gatti, Laura a Polizzi, Donatella a Pratesi, Graziella a Supino, Rosanna a Zunino, Franco a

a NATIONAL CANCER INSTITUTE (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BUFURALOL; CYTOCHROME P450 3A; DAUNORUBICIN; DICLOFENAC; DOXORUBICIN; ELACRIDAR; EPIPODOPHYLLOTOXIN; ETOPOSIDE; GLYCOPROTEIN P; MIDAZOLAM; MULTIDRUG RESISTANCE PROTEIN; PACLITAXEL; PHENACETIN; TAXANE DERIVATIVE; VERAPAMIL; VINBLASTINE; VINCA ALKALOID; ZOSUQUIDAR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER SURVIVAL; CONTROLLED STUDY; DRUG METABOLISM; DRUG POTENCY; DRUG SELECTIVITY; DRUG STRUCTURE; ENZYME INHIBITION; HUMAN; HUMAN CELL; LEUKEMIA; LUNG CARCINOMA; MOUSE; MULTIDRUG RESISTANCE; NONHUMAN; PROTEIN EXPRESSION; TUMOR XENOGRAFT;

EID: 0035030729 PISSN: 09298673 EISSN: None Source Type: Journal
DOI: 10.2174/0929867013373903 Document Type: Article

Times cited : (121)

References (30)

1
- 0030977630
- (1997) Gen. Pharmac. , vol.28 , pp. 639
- Barrand, M.A.¹ Bagrij, T.² Neo, S.-Y.³

2
- 0030738677
- (1997) Cancer Chemother. Pharmacol. , vol.40
- Ling, V.¹

3
- 0033529672
- (1999) J Biol. Chem. , vol.274 , pp. 22877
- Stride, B.D.¹ Cole, S.P.C.² Deeley, R.G.³

4
- 0030863293
- (1997) J Biol Chem , vol.272 , pp. 23623
- Hipfner, D.R.¹ Almquist, K.C.² Leslie, E.M.³ Gerlach, J.H.⁴ Grant, C.E.⁵ Deeley, R.G.⁶ Cole, S.P.C.⁷

5
- 0032412569
- (1998) Cytotechnology , vol.27 , pp. 1
- Bosch, I.¹ Croop, J.M.²

6
- 0027960078
- (1994) Cancer Res. , vol.54 , pp. 5902
- Cole, S.P.C.¹ Sparks, K.E.² Fraser, K.³ Loe, D.W.⁴ Grant, C.E.⁵ Wilson, G.M.⁶ Deeley, R.G.⁷

7
- 0028054888
- (1994) Cancer Res. , vol.54 , pp. 357
- Grant, C.E.¹ Valdimarsson, G.² Hipfner, D.R.³ Almquist, K.C.⁴ Cole, S.P.C.⁵ Deeley, R.G.⁶

8
- 0025007511
- (1990) Pharmacol. Reviews , vol.42 , pp. 155
- Ford, J.M.¹ Hait, W.N.²

9
- 0026300070
- (1991) Cancer Treat Res , vol.57 , pp. 151
- Beck, W.T.¹

10
- 0031158802
- (1997) Seminars In Cancer Biology , vol.8 , pp. 171
- Muller, M.¹ Sarkadi, B.²

11
- 0005089113
- (1995) Anticancer Res. , vol.15 , pp. 1
- Slate, D.L.¹ Bruno, N.A.² Casey, S.M.³ Zutshi, N.⁴ Garvin, L.J.⁵ Wu, H.⁶ Pfister, J.R.⁷

12
- 0028790019
- (1995) Bioogr. Med. Chem. Lett. , vol.5 , pp. 2473
- Pfister, J.R.¹ Makra, F.² Muehldorf, A.V.³ Wu, H.⁴ Nelson, J.T.⁵ Cheung, P.⁶ Bruno, N.A.⁷ Casey, S.M.⁸ Zutshi, N.⁹ Slate, D.L.¹⁰

13
- 0029809499
- (1996) J. Cancer Res. , vol.56 , pp. 4171
- Dantzig, A.H.¹ Shepard, R.L.² Cao, J.³ Law, K.L.⁴ Ehlhardt, W.J.⁵ Baughman, T.M.⁶ Bumol, T.⁷ Starling, J.⁸

14
- 0030769833
- (1997) Adv. Enz. Regul. , vol.37 , pp. 335
- Starling, J.J.¹ Shepard, R.L.² Cao, J.³ Law, K.L.⁴ Norman, B.H.⁵ Kroin, J.S.⁶ Ehlhardt, W.J.⁷ Baughman, T.M.⁸ Winter, M.A.⁹ Bell, M.G.¹⁰ Shih, C.¹¹ Gruber, J.¹² Elmquist, W.F.¹³ Dantzig, A.H.¹⁴

15
- 0022458951
- (1986) Cancer Res. , vol.46 , pp. 4053
- Marsh, W.¹ Sicheri, D.² Center, M.³

16
- 0032763895
- (1999) JPET , vol.290 , pp. 854
- Dantzig, A.H.¹ Shepard, R.L.² Law, K.L.³ Tabas, L.⁴ Pratt, S.⁵ Gillespie, J.S.⁶ Binkley, S.N.⁷ Kuhfeld, M.T.⁸ Starling, J.J.⁹ Wrighton, S.A.¹⁰

17
- 0032449122
- (1998) Drugs of the Future , vol.23 , pp. 1001
- Norman, B.H.¹

18
- 0002769936
- Pharmacokinetics: The dynamics of drug absorption, distribution and elimination
- Goodman and Gilman's: The Pharmacological Basis of Therapeutics., J.G. Hardman, et al., Editors. McGraw-Hill: New York.
- (1996) , pp. 14
- Benet, L.¹ Kroetz, D.² Sheiner, L.³

19
- 0029028792
- (1995) Mol Carcinog. , vol.13 , pp. 129
- Wacher, V.J.¹ Wu, C.Y.² Benet, L.Z.³

20
- 0024554928
- (1989) Adv. Canc. Res. , vol.52 , pp. 165
- van der Bliek, A.M.¹ Borst, P.²

21
- 0030738096
- (1997) Cancer Chem. Pharmacol. , vol.40
- Sikie, B.I.¹ Fisher, G.A.² Lum, B.L.³ Halsey, J.⁴ Beketic-Oreskovic, L.⁵ Chen, G.⁶

22
- 0001223675
- (1998) Drug Resistance Updates , vol.1 , pp. 190
- Sandor, V.¹ Fojo, T.² Bates, S.E.³

23
- 0027136660
- (1993) Cancer , vol.72 , pp. 3553
- Raderer, M.¹ Scheithauer, W.²

24
- 0027518135
- (1993) Cancer , vol.72 , pp. 3502
- Lum, B.L.¹ Fisher, G.A.² Brophy, N.A.³ Yahanda, A.M.⁴ Adler, K.M.⁵ Kaubisch, S.⁶ Halsey, J.⁷ Sikic, B.I.⁸

25
- 0005085502
- Continous intravenous infusion of LY335979, a P-glycoprotein modulator, administered in combination with doxorubicin: Results of a phase I dose-escalating trial ASCO. Baltimore, MD: AACR.
- (1999)
- Sweeney, C.¹ Sandler, A.² Luffer-Atlas, D.³ Chaudhary, A.⁴ Green, L.⁵ Marder, P.⁶ Jordan, C.⁷ Skerjanec, A.⁸ Slapak, C.⁹

26
- 0005070321
- (1999) Annals of Oncology , vol.9 , pp. 553
- Rubin, E.¹ Zamek, R.² Median, M.³ Toppmeyer, D.⁴ Luffer-Atlas, E.⁵ Chaudhary, A.⁶ Green, L.⁷ Marder, P.C.J.⁸ Skerjanec, A.⁹ Slapak, C.¹⁰

27
- 0032960840
- (1999) Blood , vol.93 , pp. 306
- Robey, R.¹ Bakke, S.² Stein, W.³ Meadows, B.⁴ Litman, T.⁵ Patil, S.⁶ Smith, T.⁷ Fojo, T.⁸ Bates, S.⁹

28
- 0030041652
- (1996) Clin Cancer Res. , vol.2 , pp. 7
- Witherspoon, S.M.¹ Emerson, D.L.² Kerr, B.M.³ Lloyd, T.L.⁴ Dalton, W.S.⁵ Wissel, P.S.⁶

29
- 0005041411
- P-glycoprotein targeted pharmacologic activity detected during clinical evaluations of LY335979. in AACR. Philapelphia, PA: Cadmus Journal Services.
- (1999)
- Green, L.¹ Marder, P.² Skerjanec, A.³ Rubin, E.⁴ Sandler, A.⁵ Slapak, C.⁶

30
- 0023447098
- (1987) Proc. Natl. Acad. Sci. USA , vol.84 , pp. 7735
- Thiebaut, F.¹ Tsuruo, T.² Hamada, H.³ Gottesman, M.M.⁴ Pastan, I.⁵ Willingham, M.C.⁶

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.